A.D.H.D is a fairly common diagnosis, but some researchers are wondering if we should start taking a more nuanced approach to treatment. Paul Tough is a contributing writer for The New York Times Magazine, and he joins host Krys Boyd to talk about why A.D.H.D. might be experienced by anyone at a given time and might not be a permanent diagnosis, and why doctors are rethinking standard stimulant medications. His article is “Have We Been Thinking About A.D.H.D. All Wrong?”